Editorial: Radiotherapy for esophageal cancer: Molecular mechanism and novel targets to improve radiosensitivity
Front Oncol
.
2023 Apr 3:13:1188010.
doi: 10.3389/fonc.2023.1188010.
eCollection 2023.
Authors
Yanqing Liu
1
,
Adam Yongxin Ye
2
,
Jordan Lu
1
,
Jiaxing Yang
1
,
Xiao Zheng
3
,
Xiaodong Li
4
5
Affiliations
1
Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY, United States.
2
Howard Hughes Medical Institute, Boston Children's Hospital, Harvard Medical School, Boston, MA, United States.
3
Department of Tumor Biological Treatment, The Third Affiliated Hospital of Soochow University, Changzhou, China.
4
Africa Hepatopancreatobiliary Cancer Consortium (AHPBCC), Mayo Clinic, Jacksonville, FL, United States.
5
Department of Oncology, Third Affiliated Hospital of Soochow University, Changzhou, China.
PMID:
37077829
PMCID:
PMC10109320
DOI:
10.3389/fonc.2023.1188010
No abstract available
Keywords:
chemotherapy; esophageal cancer; overall survival; prognostic marker; radiotherapy.
Publication types
Editorial